Endocrine

, Volume 41, Issue 3, pp 512–517 | Cite as

High prevalence of radiological vertebral fractures in HIV-infected males

  • Carlo Torti
  • Gherardo Mazziotti
  • Pier Antonio Soldini
  • Emanuele Focà
  • Roberto Maroldi
  • Daria Gotti
  • Giampiero Carosi
  • Andrea Giustina
Original Article

Abstract

Age-related co-morbidities including osteoporosis are relevant in patients responding to combination antiretroviral therapy (cART). Vertebral fractures are common osteoporotic fractures and their diagnosis is useful for managing at-risk individuals. However, there are few data from HIV-infected patients. Therefore, the aim of this study was to determine the prevalence of and factors associated with vertebral fractures in a population of HIV-infected males. A cross-sectional study of 160 HIV-infected patients with available chest X-rays was conducted from 1998 to 2010. One hundred and sixty-three males with comparable age and with no history of HIV infection were recruited as controls. Semi-quantitative evaluation of vertebral heights in lateral chest X-rays and quantitative morphometry assessment of centrally digitized images using dedicated morphometry software were utilized to detect prevalent vertebral fractures. The result showed that the vertebral fractures were detected in 43/160 (26.9%) HIV-infected patients and in 21/163 (12.9%) controls (P = 0.002). In HIV-infected patients with fractures, 27 had two or more fractures and ten patients had severe fractures. The prevalence of any fractures and multiple fractures in HIV-infected patients receiving cART (29.6 and 20.0%) was slightly higher than in HIV-infected patients not exposed to cART (17.1 and 5.7%), but significantly higher than control subjects (12.9 and 3.7%). At multivariable analyses, body mass index and diabetes mellitus were independently correlated with vertebral fractures in HIV-infected patients. We concluded that a significant proportion of HIV-infected males receiving cART showed vertebral fractures. Furthermore, proactive diagnosis of vertebral fragility fractures is particularly relevant in patients who are overweight or suffer from diabetes.

Keywords

Vertebral fracture HIV Antiretroviral therapy Osteoporosis 

Notes

Acknowledgments

We thank Alfredo Scalzini MD, Filippo Castelnuovo MD, Davide Motta MD, DR Laura Albini, Daniele Distefano MD for the contribution in data collection. We also thank all the colleagues working at the Departments of Infectious Diseases and Radiology of the University of Brescia for providing assistance to patients, whose data served for the conduction of this study, and the patients themselves.

Conflict of interest

CT, EF and GC have received unrestricted educational grants (as speakers or for participation to conferences) from Abbott, Gilead, Merck, GlaxoSmithKline, Bristol Myers Squibb, Schering Plough and Roche Spa. The other authors report no relevant disclosures or associations with industry.

References

  1. 1.
    A.D. Gutierrez, A. Balasubramanyam, Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Endocrine (2011). doi: 10.1007/s12020-011-9565-7
  2. 2.
    C. Gazzaruso, R. Bruno, A. Garzaniti et al., Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J. Hypertens. 21(7), 1377–1382 (2003)PubMedCrossRefGoogle Scholar
  3. 3.
    R. Bruno, C. Gazzaruso, P. Sacchi et al., High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk. J. Acquir. Immune Defic. Syndr. 31(3), 363–365 (2002)PubMedCrossRefGoogle Scholar
  4. 4.
    P. Sambrook, C. Cooper, Osteoporosis. Lancet 367(9527), 2010–2018 (2006)PubMedCrossRefGoogle Scholar
  5. 5.
    J.M. Fakruddin, J. Laurence, HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity. Arch. Virol. 150(1), 67–78 (2005)PubMedCrossRefGoogle Scholar
  6. 6.
    D. Gibellini, E. de Crignis, C. Ponti et al., HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation. J. Med. Virol. 80(9), 1507–1514 (2008)PubMedCrossRefGoogle Scholar
  7. 7.
    T.T. Brown, R.B. Qaqish, Antiretroviral therapy and the prevalence of osteopenia and ostoporosis: a meta-analytic review. AIDS 20, 2165–2174 (2006)PubMedCrossRefGoogle Scholar
  8. 8.
    B. Young, C.N. Dao, K. Buchacz, R. Baker, J.T. Brooks, Increased rates of bone fracture among HIV-infected persons in the HIV outpatient study (HOPS) compared with the US general population, 2000–2006. Clin. Infect. Dis. 52(8), 1061–1068 (2011)PubMedCrossRefGoogle Scholar
  9. 9.
    J.A. Womack, J.L. Goulet, C. Gibert, Increased risk of fragility fractures among HIV infected compared to uninfected male. PLoS ONE 6(2), e17217 (2011)PubMedCrossRefGoogle Scholar
  10. 10.
    V.A. Triant, T.T. Brown, H. Lee, S.K. Grinspoon, Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J. Clin. Endocrinol. Metab. 93, 3499–3504 (2008)PubMedCrossRefGoogle Scholar
  11. 11.
    J.H. Arnsten, R. Freeman, A.A. Howard et al., Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 21(5), 617–623 (2007)PubMedCrossRefGoogle Scholar
  12. 12.
    P. Vestergaard, Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos. Int. 18(4), 427–444 (2007)PubMedCrossRefGoogle Scholar
  13. 13.
    G. Mazziotti, A. Bianchi, S. Bonadonna et al., Prevalence of vertebral fractures in men with acromegaly. J. Clin. Endocrinol. Metab. 93(12), 4649–4655 (2008)PubMedCrossRefGoogle Scholar
  14. 14.
    K.E. Ensrud, J.T. Schousboe, Vertebral fractures. N. Engl. J. Med. 364, 1634–1642 (2011)PubMedCrossRefGoogle Scholar
  15. 15.
    A. Angeli, G. Guglielmi, A. Dovio et al., High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone 39(2), 253–259 (2006)PubMedCrossRefGoogle Scholar
  16. 16.
    M. Grigoryan, A. Guermazi, F.W. Roemer, P.D. Delmas, H.K. Genant, Recognizing and reporting osteoporotic vertebral fractures. Eur. Spine J. 12, S104–S112 (2003)PubMedCrossRefGoogle Scholar
  17. 17.
    G. Mazziotti, E. Canalis, A. Giustina, Drug-induced osteoporosis: mechanisms and clinical implications. Am. J. Med. 123(10), 877–884 (2010)PubMedCrossRefGoogle Scholar
  18. 18.
    H.K. Genant, M. Jergas, L. Palermo et al., Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. The Study of Osteoporotic Fractures Research Group. J. Bone Miner. Res. 11(7), 984–996 (1996)PubMedCrossRefGoogle Scholar
  19. 19.
    J.A. Kanis, E.V. McCloskey, H. Johansson, et al., Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK. Osteoporos. Int. 20, 449–502 (2009)Google Scholar
  20. 20.
    WHO, Fracture Risk Assessment Tool. Available at: http://www.shef.ac.uk/FRAX
  21. 21.
    N.B. Khazai, G.R. Beck Jr, G.E. Umpierrez, Diabetes and fractures: an overshadowed association. Curr. Opin. Endocrinol. Diabetes Obes. 16, 435–445 (2009)PubMedCrossRefGoogle Scholar
  22. 22.
    S.K. Grinspoon, A. Carr, Cardiovascular risk and body fat abnormalities in HIV-infected adults. N. Engl. J. Med. 352, 48–62 (2005)PubMedCrossRefGoogle Scholar
  23. 23.
    I. Kanazawa, T. Yamaguchi, M. Yamamoto, M. Yamauchi, S. Yano, T. Sugimoto, Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcif. Tissue Int. 83, 324–331 (2008)PubMedCrossRefGoogle Scholar
  24. 24.
    C. De Laet, J.A. Kanis, A. Ode′n et al., Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos. Int. 16, 1330–1338 (2005)PubMedCrossRefGoogle Scholar
  25. 25.
    M. Iki , J. Tamaki, Y. Fujita et al., Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos. Int. (2011). doi: 10.1007/s00198-011-1733-8
  26. 26.
    M.P. Dubè, Disorders of glucose metabolism in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 31(6), 1467–1475 (2000)PubMedCrossRefGoogle Scholar
  27. 27.
    T.T. Brown, M.D. Ruppe, R. Kassner et al., Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J. Clin. Endocrinol. Metab. 89(3), 1200–1206 (2004)PubMedCrossRefGoogle Scholar
  28. 28.
    D.M. Wunder, N.A. Bersinger, C.A. Fux et al., Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antivir. Ther. 12, 261–265 (2007)PubMedGoogle Scholar
  29. 29.
    J.E. Gallant, S. Staszewski, A.L. Pozniak et al., Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naïve patients: a 3-year randomized trial. JAMA 292(2), 191–201 (2004)PubMedCrossRefGoogle Scholar
  30. 30.
    G.A. McComsey, D. Kitch, E.S. Daar et al., Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: AIDS Clinical Trials Group A5224s, a substudy of ACTG A5202. J. Infect. Dis. 203(12), 1791–1801 (2011)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Carlo Torti
    • 1
  • Gherardo Mazziotti
    • 2
    • 3
  • Pier Antonio Soldini
    • 4
  • Emanuele Focà
    • 1
  • Roberto Maroldi
    • 4
  • Daria Gotti
    • 1
  • Giampiero Carosi
    • 1
  • Andrea Giustina
    • 2
  1. 1.Institute of Infectious and Tropical Diseases, School of MedicineUniversity of BresciaBresciaItaly
  2. 2.Department of Medical and Surgical SciencesUniversity of BresciaBresciaItaly
  3. 3.Department of Medicine“Carlo Poma” HospitalMantuaItaly
  4. 4.Department of RadiologyUniversity of BresciaBresciaItaly

Personalised recommendations